American International Group’s Rosetta Genomics Ltd. ROSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-50
Closed -$1.85K 5257
2015
Q1
$1.85K Sell
50
-39
-44% -$1.48K ﹤0.01% 4859
2014
Q4
$2.41K Hold
89
﹤0.01% 4794
2014
Q3
$3.74K Buy
89
+39
+78% +$1.77K ﹤0.01% 4749
2014
Q2
$2.59K Hold
50
﹤0.01% 4733
2014
Q1
$2.99K Hold
50
﹤0.01% 4642
2013
Q4
$1.75K Hold
50
﹤0.01% 4628
2013
Q3
$1.91K Sell
50
-54
-52% -$2.19K ﹤0.01% 4531
2013
Q2
$4.24K Buy
+104
New +$4.62K ﹤0.01% 4311

Other funds holding ROSG

American International Group's ROSG Position: Q2 2015 in Review

American International Group sold out of Rosetta Genomics Ltd. (ROSG) in Q2 2015, closing a stake of 50 shares — an estimated $1.85K sold.

American International Group first reported a position in ROSG in Q2 2013 and held it in 8 quarters. The position peaked at $4.24K in Q2 2013. 11 funds tracked by Wall St. Rank hold ROSG as of Q2 2015.

  • American International Group reported no remaining Rosetta Genomics Ltd. position as of Q2 2015 after selling out during the quarter.
  • American International Group sold 50 Rosetta Genomics Ltd. shares in Q2 2015, an estimated $1.85K.
  • American International Group first reported a position in Rosetta Genomics Ltd. in Q2 2013 and held it in 8 quarters.
  • American International Group's Rosetta Genomics Ltd. position peaked at $4.24K in Q2 2013.
  • 11 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2015.

Based on American International Group's 13F filing for Q2 2015, filed 12 Aug 2015.